���ϳԹ���

Stanton L. Gerson, director of the Case Comprehensive Cancer Center, wrote a guest column for The Plain Dealer about Vice President Joe Biden’s Cancer Moonshot. His column, titled “Cleveland matters for Vice President Biden's Cancer Moonshot,” detailed how teams in Cleveland have worked with the vi...

Changes in benign tissues next to prostate tumors may provide an early warning for patients at higher risk for biochemical recurrence after a radical prostatectomy, a study by researchers at ���ϳԹ��� and Johns Hopkins Medical Institutions shows. Biochemical recurrence, which ...

Message from the Associate Director: Brian Bolwell, MD Thomas Donohue, President and CEO, US Chamber of Commerce, hosted a Cancer Moonshot Breakfast Panel in downtown Cleveland last Wednesday. I participated in the panel, along with Toby Cosgrove, MD, President and CEO of Cleveland Clinic, Louis D...

Many of us are concerned with improving the cost of care in the setting of major cancer care centers, such as those at Cleveland Clinic and Seidman Cancer Center and their network sites. A publication from members of the National Comprehensive Cancer Network (NCCN) on the "Value Access Cost of Canc...

Phenanthriplatin outperformed cisplatin in mouse model of triple-negative breast cancer when encapsulated into nanocarrier In a pair of firsts, researchers at ���ϳԹ��� and Massachusetts Institute of Technology have shown that the drug candidate phenanthriplatin can be more eff...

Case Comprehensive Cancer Center welcomes Monica Webb Hooper, PhD as Director of the new Office of Cancer Disparities Research. She is also Professor of General Medical Sciences (Oncology), Family Medicine, Epidemiology & Biostatistics, and Psychological Sciences at ���ϳԹ��� S...

Findings lay groundwork for human clinical trial planned for August 2016 A new scientific study has identified why colorectal cancer cells depend on a specific nutrient, and a way to starve them of it. Over one million men and women are living with colorectal cancer in the United States. The Nation...

National Cancer Institute awards $3.3 million to develop digital image analytics Researchers from ���ϳԹ��� are teaming with industry and other academics to develop a quick and inexpensive test to predict which women with ER+ breast cancer need chemotherapy and which need only ...

Guest Author: Greg Cooper Colorectal cancer remains the second leading cause of cancer death in this country, though over the past decade, both the incidence and mortality have been declining. Colorectal screening is universally recommended as a means to detect premalignant adenomas as well as ear...

Having Vice President Joe Biden kick-off the post Cancer Moonshot Summit national campaign in Cleveland - what a day!! The Vice President came to the Case Comprehensive Cancer Center because we proposed a concerted effort to develop interventional science driven ...